Better treatments for gastric cancer in Latino patients
Advancing gastric cancer precision medicine in Latinos through patient-derived modeling
This research aims to find more effective and personalized treatments for gastric cancer, especially for Latino patients who face higher rates of this disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11168895 on NIH RePORTER |
What this research studies
Gastric cancer is a serious health concern, particularly for Latino communities in the U.S., where incidence and mortality rates are significantly higher. Our team is working to understand why these disparities exist and to develop new treatment options. We are creating models from patient tumors to test different medications and identify which ones work best for specific types of gastric cancer found in Latino patients. This approach helps us tailor treatments more precisely, moving towards personalized medicine.
Who could benefit from this research
Good fit: This research focuses on understanding gastric cancer in Latino patients, especially those with specific genetic changes in their tumors.
Not a fit: Patients without gastric cancer or those whose tumors do not match the specific genetic profiles being studied may not directly benefit from this particular research.
Why it matters
Potential benefit: If successful, this work could lead to new, more effective, and personalized treatment strategies for gastric cancer, particularly benefiting Latino patients.
How similar studies have performed: Previous work by this team has shown that many gastric tumors in Latino patients have genetic changes that could be targeted by existing drugs, suggesting a promising path forward.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Carvajal Carmona, Luis Guillermo — University of California at Davis
- Study coordinator: Carvajal Carmona, Luis Guillermo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.